Lv1
10 积分 2025-02-27 加入
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
6个月前
已完结
Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review
6个月前
已完结
Autismus und autistische Störungen
6个月前
已完结
Introducing equivalent and threshold doses in the assessment of medication-related osteonecrosis of the jaw risk: insights from a descriptive study in Iran
8个月前
已完结
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
9个月前
已完结
皖公网安备34019202002308
